Industry Research Reports

Home > Reports > Service & Software > Genome Sequencing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Genome Sequencing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-03-06

Pages: 139 Pages

Report ld: 6024428

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Genome Sequencing Service Market Size(US$)

CAGR 2026-2032

18.0%

Market Size,2032

USD 88,040

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 32,680 million

Market Forecast in 2032(Value)

US$ 88,040 million

CAGR

18.0%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Genome Sequencing Service was estimated to be worth US$ 28130 million in 2025 and is projected to reach US$ 88040 million, growing at a CAGR of 18.0% from 2026 to 2032.

Genome Sequencing Service refers to a comprehensive biotechnology service provided by professional organizations, leveraging high-throughput sequencing platforms, bioinformatics analysis technologies, and standardized experimental procedures. This service offers integrated genomic DNA extraction, sequencing, data interpretation, and analysis to clients such as research institutions, medical institutions, and enterprises. Its core principle is to read the base sequences of the entire genome or specific gene fragments of an organism or species using sequencing equipment, and then combine this with bioinformatics tools to analyze the genetic information contained within the sequences. Ultimately, this provides precise genetic data support for basic scientific research, disease diagnosis, agricultural breeding, and other fields.

Clinical diagnosis has long been the core application of this service, and its use continues to deepen. In the field of oncology, sequencing-based targeted therapy has become the mainstream approach, and technologies such as liquid biopsy are driving the service to extend from treatment guidance to early screening. In the field of genetic disease screening, non-invasive prenatal testing has become widespread, and the advancement of the Newborn Genome Project has further expanded the service coverage. Furthermore, sequencing services are increasingly being used for medication guidance in chronic diseases, reducing adverse drug reactions and achieving precision medicine.

Beyond the medical field, sequencing services are rapidly penetrating into agriculture, microbiology, and other fields. In agriculture, sequencing helps uncover genes related to crop stress resistance and high yield, aiding in the breeding of superior varieties and ensuring food security. In the field of microbiology, metagenomic sequencing eliminates the need for strain isolation and culture, enabling the identification of pathogenic microorganisms and analysis of gut microbiota diversity, and is widely used in public health and disease prevention as well as biomedical research and development. Simultaneously, its applications in forensic identification and endangered species protection are also being explored.

This report provides a comprehensive view of the global market for Genome Sequencing Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Genome Sequencing Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Genome Sequencing Service.

MARKET SEGMENTATION

By Company

Illumina
Thermo Fisher Scientific
BGI Genomics
Agilent Technologies
CD Genomics
Azenta Life Sciences
Broad Clinical Labs
Macrogen
GE Healthcare Life Sciences
Johnson & Johnson
Abbott Laboratories
Bayer
Microchip Biotechnologies
GeneDx
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Novogene
Eurofins Genomics
Psomagen

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Whole-Genome Sequencing
Whole exome Sequencing
Others

Segment by Application

Humanity
Plant
Animal
Microorganism
Virus

Segment by Category

Scientific Research
Clinical
Agriculture
Others

Segment by Division

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Genome Sequencing Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Genome Sequencing Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Genome Sequencing Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Genome Sequencing Service Product Introduction

1.2 Global Genome Sequencing Service Market Size Forecast (2021–2032)

1.3 Genome Sequencing Service Market Trends & Drivers

1.3.1 Genome Sequencing Service Industry Trends

1.3.2 Genome Sequencing Service Market Drivers & Opportunities

1.3.3 Genome Sequencing Service Market Challenges

1.3.4 Genome Sequencing Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Genome Sequencing Service Players Revenue Ranking (2025)

2.2 Global Genome Sequencing Service Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Genome Sequencing Service Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Genome Sequencing Service

2.6 Genome Sequencing Service Market Competitive Analysis

2.6.1 Genome Sequencing Service Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Genome Sequencing Service Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Genome Sequencing Service revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Genome Sequencing Service Market Classification

3.1 Introduction by Type

3.1.1 Whole-Genome Sequencing

3.1.2 Whole exome Sequencing

3.1.3 Others

3.1.4 Global Genome Sequencing Service Sales Value by Type

3.1.4.1 Global Genome Sequencing Service Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Genome Sequencing Service Sales Value, by Type (2021–2032)

3.1.4.3 Global Genome Sequencing Service Sales Value, by Type (%), 2021–2032

3.2 Introduction by Scene

3.2.1 Scientific Research

3.2.2 Clinical

3.2.3 Agriculture

3.2.4 Others

3.2.5 Global Genome Sequencing Service Sales Value by Scene

3.2.5.1 Global Genome Sequencing Service Sales Value by Scene (2021 vs 2025 vs 2032)

3.2.5.2 Global Genome Sequencing Service Sales Value, by Scene (2021–2032)

3.2.5.3 Global Genome Sequencing Service Sales Value, by Scene (%), 2021–2032

3.3 Introduction by Genome

3.3.1 DNA

3.3.2 RNA

3.3.3 Global Genome Sequencing Service Sales Value by Genome

3.3.3.1 Global Genome Sequencing Service Sales Value by Genome (2021 vs 2025 vs 2032)

3.3.3.2 Global Genome Sequencing Service Sales Value, by Genome (2021–2032)

3.3.3.3 Global Genome Sequencing Service Sales Value, by Genome (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Humanity

4.1.2 Plant

4.1.3 Animal

4.1.4 Microorganism

4.1.5 Virus

4.2 Global Genome Sequencing Service Sales Value by Application

4.2.1 Global Genome Sequencing Service Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Genome Sequencing Service Sales Value by Application (2021–2032)

4.2.3 Global Genome Sequencing Service Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Genome Sequencing Service Sales Value by Region

5.1.1 Global Genome Sequencing Service Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Genome Sequencing Service Sales Value by Region (2021–2026)

5.1.3 Global Genome Sequencing Service Sales Value by Region (2027–2032)

5.1.4 Global Genome Sequencing Service Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Genome Sequencing Service Sales Value, 2021–2032

5.2.2 North America Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Genome Sequencing Service Sales Value, 2021–2032

5.3.2 Europe Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Genome Sequencing Service Sales Value, 2021–2032

5.4.2 Asia Pacific Genome Sequencing Service Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Genome Sequencing Service Sales Value, 2021–2032

5.5.2 South America Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Genome Sequencing Service Sales Value, 2021–2032

5.6.2 Middle East & Africa Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Genome Sequencing Service Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Genome Sequencing Service Sales Value, 2021–2032

6.3 United States

6.3.1 United States Genome Sequencing Service Sales Value, 2021–2032

6.3.2 United States Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Genome Sequencing Service Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Genome Sequencing Service Sales Value, 2021–2032

6.4.2 Europe Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Genome Sequencing Service Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Genome Sequencing Service Sales Value, 2021–2032

6.5.2 China Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

6.5.3 China Genome Sequencing Service Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Genome Sequencing Service Sales Value, 2021–2032

6.6.2 Japan Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Genome Sequencing Service Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Genome Sequencing Service Sales Value, 2021–2032

6.7.2 South Korea Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Genome Sequencing Service Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Genome Sequencing Service Sales Value, 2021–2032

6.8.2 Southeast Asia Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Genome Sequencing Service Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Genome Sequencing Service Sales Value, 2021–2032

6.9.2 India Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

6.9.3 India Genome Sequencing Service Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Illumina

7.1.1 Illumina Profile

7.1.2 Illumina Main Business

7.1.3 Illumina Genome Sequencing Service Products, Services, and Solutions

7.1.4 Illumina Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.1.5 Illumina Recent Developments

7.2 Thermo Fisher Scientific

7.2.1 Thermo Fisher Scientific Profile

7.2.2 Thermo Fisher Scientific Main Business

7.2.3 Thermo Fisher Scientific Genome Sequencing Service Products, Services, and Solutions

7.2.4 Thermo Fisher Scientific Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.2.5 Thermo Fisher Scientific Recent Developments

7.3 BGI Genomics

7.3.1 BGI Genomics Profile

7.3.2 BGI Genomics Main Business

7.3.3 BGI Genomics Genome Sequencing Service Products, Services, and Solutions

7.3.4 BGI Genomics Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.3.5 BGI Genomics Recent Developments

7.4 Agilent Technologies

7.4.1 Agilent Technologies Profile

7.4.2 Agilent Technologies Main Business

7.4.3 Agilent Technologies Genome Sequencing Service Products, Services, and Solutions

7.4.4 Agilent Technologies Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.4.5 Agilent Technologies Recent Developments

7.5 CD Genomics

7.5.1 CD Genomics Profile

7.5.2 CD Genomics Main Business

7.5.3 CD Genomics Genome Sequencing Service Products, Services, and Solutions

7.5.4 CD Genomics Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.5.5 CD Genomics Recent Developments

7.6 Azenta Life Sciences

7.6.1 Azenta Life Sciences Profile

7.6.2 Azenta Life Sciences Main Business

7.6.3 Azenta Life Sciences Genome Sequencing Service Products, Services, and Solutions

7.6.4 Azenta Life Sciences Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.6.5 Azenta Life Sciences Recent Developments

7.7 Broad Clinical Labs

7.7.1 Broad Clinical Labs Profile

7.7.2 Broad Clinical Labs Main Business

7.7.3 Broad Clinical Labs Genome Sequencing Service Products, Services, and Solutions

7.7.4 Broad Clinical Labs Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.7.5 Broad Clinical Labs Recent Developments

7.8 Macrogen

7.8.1 Macrogen Profile

7.8.2 Macrogen Main Business

7.8.3 Macrogen Genome Sequencing Service Products, Services, and Solutions

7.8.4 Macrogen Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.8.5 Macrogen Recent Developments

7.9 GE Healthcare Life Sciences

7.9.1 GE Healthcare Life Sciences Profile

7.9.2 GE Healthcare Life Sciences Main Business

7.9.3 GE Healthcare Life Sciences Genome Sequencing Service Products, Services, and Solutions

7.9.4 GE Healthcare Life Sciences Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.9.5 GE Healthcare Life Sciences Recent Developments

7.10 Johnson & Johnson

7.10.1 Johnson & Johnson Profile

7.10.2 Johnson & Johnson Main Business

7.10.3 Johnson & Johnson Genome Sequencing Service Products, Services, and Solutions

7.10.4 Johnson & Johnson Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.10.5 Johnson & Johnson Recent Developments

7.11 Abbott Laboratories

7.11.1 Abbott Laboratories Profile

7.11.2 Abbott Laboratories Main Business

7.11.3 Abbott Laboratories Genome Sequencing Service Products, Services, and Solutions

7.11.4 Abbott Laboratories Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.11.5 Abbott Laboratories Recent Developments

7.12 Bayer

7.12.1 Bayer Profile

7.12.2 Bayer Main Business

7.12.3 Bayer Genome Sequencing Service Products, Services, and Solutions

7.12.4 Bayer Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.12.5 Bayer Recent Developments

7.13 Microchip Biotechnologies

7.13.1 Microchip Biotechnologies Profile

7.13.2 Microchip Biotechnologies Main Business

7.13.3 Microchip Biotechnologies Genome Sequencing Service Products, Services, and Solutions

7.13.4 Microchip Biotechnologies Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.13.5 Microchip Biotechnologies Recent Developments

7.14 GeneDx

7.14.1 GeneDx Profile

7.14.2 GeneDx Main Business

7.14.3 GeneDx Genome Sequencing Service Products, Services, and Solutions

7.14.4 GeneDx Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.14.5 GeneDx Recent Developments

7.15 Commonwealth Biotechnologies

7.15.1 Commonwealth Biotechnologies Profile

7.15.2 Commonwealth Biotechnologies Main Business

7.15.3 Commonwealth Biotechnologies Genome Sequencing Service Products, Services, and Solutions

7.15.4 Commonwealth Biotechnologies Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.15.5 Commonwealth Biotechnologies Recent Developments

7.16 ZS Genetics

7.16.1 ZS Genetics Profile

7.16.2 ZS Genetics Main Business

7.16.3 ZS Genetics Genome Sequencing Service Products, Services, and Solutions

7.16.4 ZS Genetics Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.16.5 ZS Genetics Recent Developments

7.17 Pacific Biosciences

7.17.1 Pacific Biosciences Profile

7.17.2 Pacific Biosciences Main Business

7.17.3 Pacific Biosciences Genome Sequencing Service Products, Services, and Solutions

7.17.4 Pacific Biosciences Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.17.5 Pacific Biosciences Recent Developments

7.18 Novogene

7.18.1 Novogene Profile

7.18.2 Novogene Main Business

7.18.3 Novogene Genome Sequencing Service Products, Services, and Solutions

7.18.4 Novogene Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.18.5 Novogene Recent Developments

7.19 Eurofins Genomics

7.19.1 Eurofins Genomics Profile

7.19.2 Eurofins Genomics Main Business

7.19.3 Eurofins Genomics Genome Sequencing Service Products, Services, and Solutions

7.19.4 Eurofins Genomics Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.19.5 Eurofins Genomics Recent Developments

7.20 Psomagen

7.20.1 Psomagen Profile

7.20.2 Psomagen Main Business

7.20.3 Psomagen Genome Sequencing Service Products, Services, and Solutions

7.20.4 Psomagen Genome Sequencing Service Revenue (US$ Million), 2021–2026

7.20.5 Psomagen Recent Developments

8 Industry Chain Analysis

8.1 Genome Sequencing Service Value Chain

8.2 Genome Sequencing Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Genome Sequencing Service Sales Model

8.5.2 Sales Channels

8.5.3 Genome Sequencing Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Genome Sequencing Service Market Trends

Table 2. Genome Sequencing Service Market Drivers & Opportunities

Table 3. Genome Sequencing Service Market Challenges

Table 4. Genome Sequencing Service Market Restraints

Table 5. Global Genome Sequencing Service Revenue by Company (US$ Million), 2021–2026

Table 6. Global Genome Sequencing Service Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Genome Sequencing Service Product Type

Table 9. Key Companies General Availability (GA) Timeline for Genome Sequencing Service

Table 10. Global Genome Sequencing Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Genome Sequencing Service revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Genome Sequencing Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Genome Sequencing Service Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Genome Sequencing Service Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Genome Sequencing Service Sales Market Share in Value by Type (2021–2026)

Table 17. Global Genome Sequencing Service Sales Market Share in Value by Type (2027–2032)

Table 18. Global Genome Sequencing Service Sales Value by Scene: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Genome Sequencing Service Sales Value by Scene (US$ Million), 2021–2026

Table 20. Global Genome Sequencing Service Sales Value by Scene (US$ Million), 2027–2032

Table 21. Global Genome Sequencing Service Sales Market Share in Value by Scene (2021–2026)

Table 22. Global Genome Sequencing Service Sales Market Share in Value by Scene (2027–2032)

Table 23. Global Genome Sequencing Service Sales Value by Genome: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Genome Sequencing Service Sales Value by Genome (US$ Million), 2021–2026

Table 25. Global Genome Sequencing Service Sales Value by Genome (US$ Million), 2027–2032

Table 26. Global Genome Sequencing Service Sales Market Share in Value by Genome (2021–2026)

Table 27. Global Genome Sequencing Service Sales Market Share in Value by Genome (2027–2032)

Table 28. Global Genome Sequencing Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Genome Sequencing Service Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Genome Sequencing Service Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Genome Sequencing Service Sales Market Share in Value by Application (2021–2026)

Table 32. Global Genome Sequencing Service Sales Market Share in Value by Application (2027–2032)

Table 33. Global Genome Sequencing Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Genome Sequencing Service Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Genome Sequencing Service Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Genome Sequencing Service Sales Value by Region (%), 2021–2026

Table 37. Global Genome Sequencing Service Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Genome Sequencing Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Genome Sequencing Service Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Genome Sequencing Service Sales Value, (US$ Million), 2027–2032

Table 41. Illumina Basic Information List

Table 42. Illumina Description and Business Overview

Table 43. Illumina Genome Sequencing Service Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Genome Sequencing Service Business of Illumina (2021–2026)

Table 45. Illumina Recent Developments

Table 46. Thermo Fisher Scientific Basic Information List

Table 47. Thermo Fisher Scientific Description and Business Overview

Table 48. Thermo Fisher Scientific Genome Sequencing Service Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Genome Sequencing Service Business of Thermo Fisher Scientific (2021–2026)

Table 50. Thermo Fisher Scientific Recent Developments

Table 51. BGI Genomics Basic Information List

Table 52. BGI Genomics Description and Business Overview

Table 53. BGI Genomics Genome Sequencing Service Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Genome Sequencing Service Business of BGI Genomics (2021–2026)

Table 55. BGI Genomics Recent Developments

Table 56. Agilent Technologies Basic Information List

Table 57. Agilent Technologies Description and Business Overview

Table 58. Agilent Technologies Genome Sequencing Service Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Genome Sequencing Service Business of Agilent Technologies (2021–2026)

Table 60. Agilent Technologies Recent Developments

Table 61. CD Genomics Basic Information List

Table 62. CD Genomics Description and Business Overview

Table 63. CD Genomics Genome Sequencing Service Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Genome Sequencing Service Business of CD Genomics (2021–2026)

Table 65. CD Genomics Recent Developments

Table 66. Azenta Life Sciences Basic Information List

Table 67. Azenta Life Sciences Description and Business Overview

Table 68. Azenta Life Sciences Genome Sequencing Service Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Genome Sequencing Service Business of Azenta Life Sciences (2021–2026)

Table 70. Azenta Life Sciences Recent Developments

Table 71. Broad Clinical Labs Basic Information List

Table 72. Broad Clinical Labs Description and Business Overview

Table 73. Broad Clinical Labs Genome Sequencing Service Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Genome Sequencing Service Business of Broad Clinical Labs (2021–2026)

Table 75. Broad Clinical Labs Recent Developments

Table 76. Macrogen Basic Information List

Table 77. Macrogen Description and Business Overview

Table 78. Macrogen Genome Sequencing Service Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Genome Sequencing Service Business of Macrogen (2021–2026)

Table 80. Macrogen Recent Developments

Table 81. GE Healthcare Life Sciences Basic Information List

Table 82. GE Healthcare Life Sciences Description and Business Overview

Table 83. GE Healthcare Life Sciences Genome Sequencing Service Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Genome Sequencing Service Business of GE Healthcare Life Sciences (2021–2026)

Table 85. GE Healthcare Life Sciences Recent Developments

Table 86. Johnson & Johnson Basic Information List

Table 87. Johnson & Johnson Description and Business Overview

Table 88. Johnson & Johnson Genome Sequencing Service Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Genome Sequencing Service Business of Johnson & Johnson (2021–2026)

Table 90. Johnson & Johnson Recent Developments

Table 91. Abbott Laboratories Basic Information List

Table 92. Abbott Laboratories Description and Business Overview

Table 93. Abbott Laboratories Genome Sequencing Service Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Genome Sequencing Service Business of Abbott Laboratories (2021–2026)

Table 95. Abbott Laboratories Recent Developments

Table 96. Bayer Basic Information List

Table 97. Bayer Description and Business Overview

Table 98. Bayer Genome Sequencing Service Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Genome Sequencing Service Business of Bayer (2021–2026)

Table 100. Bayer Recent Developments

Table 101. Microchip Biotechnologies Basic Information List

Table 102. Microchip Biotechnologies Description and Business Overview

Table 103. Microchip Biotechnologies Genome Sequencing Service Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Genome Sequencing Service Business of Microchip Biotechnologies (2021–2026)

Table 105. Microchip Biotechnologies Recent Developments

Table 106. GeneDx Basic Information List

Table 107. GeneDx Description and Business Overview

Table 108. GeneDx Genome Sequencing Service Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Genome Sequencing Service Business of GeneDx (2021–2026)

Table 110. GeneDx Recent Developments

Table 111. Commonwealth Biotechnologies Basic Information List

Table 112. Commonwealth Biotechnologies Description and Business Overview

Table 113. Commonwealth Biotechnologies Genome Sequencing Service Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Genome Sequencing Service Business of Commonwealth Biotechnologies (2021–2026)

Table 115. Commonwealth Biotechnologies Recent Developments

Table 116. ZS Genetics Basic Information List

Table 117. ZS Genetics Description and Business Overview

Table 118. ZS Genetics Genome Sequencing Service Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Genome Sequencing Service Business of ZS Genetics (2021–2026)

Table 120. ZS Genetics Recent Developments

Table 121. Pacific Biosciences Basic Information List

Table 122. Pacific Biosciences Description and Business Overview

Table 123. Pacific Biosciences Genome Sequencing Service Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Genome Sequencing Service Business of Pacific Biosciences (2021–2026)

Table 125. Pacific Biosciences Recent Developments

Table 126. Novogene Basic Information List

Table 127. Novogene Description and Business Overview

Table 128. Novogene Genome Sequencing Service Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Genome Sequencing Service Business of Novogene (2021–2026)

Table 130. Novogene Recent Developments

Table 131. Eurofins Genomics Basic Information List

Table 132. Eurofins Genomics Description and Business Overview

Table 133. Eurofins Genomics Genome Sequencing Service Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Genome Sequencing Service Business of Eurofins Genomics (2021–2026)

Table 135. Eurofins Genomics Recent Developments

Table 136. Psomagen Basic Information List

Table 137. Psomagen Description and Business Overview

Table 138. Psomagen Genome Sequencing Service Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Genome Sequencing Service Business of Psomagen (2021–2026)

Table 140. Psomagen Recent Developments

Table 141. Revenue (US$ Million) in Genome Sequencing Service Business of Company 40 (2021–2026)

Table 142. Company 40 Recent Developments

Table 143. Key Raw Materials Lists

Table 144. Key Suppliers of Raw Materials Lists

Table 145. Genome Sequencing Service Downstream Customers

Table 146. Genome Sequencing Service Distributors List

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Genome Sequencing Service Product Picture

Figure 2. Global Genome Sequencing Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 4. Genome Sequencing Service Report Years Considered

Figure 5. Global Genome Sequencing Service Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Genome Sequencing Service Revenue in 2025

Figure 7. Genome Sequencing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Whole-Genome Sequencing Picture

Figure 9. Whole exome Sequencing Picture

Figure 10. Others Picture

Figure 11. Global Genome Sequencing Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Genome Sequencing Service Sales Value Market Share by Type, 2025 & 2032

Figure 13. Scientific Research Picture

Figure 14. Clinical Picture

Figure 15. Agriculture Picture

Figure 16. Others Picture

Figure 17. Global Genome Sequencing Service Sales Value by Scene (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Genome Sequencing Service Sales Value Market Share by Scene, 2025 & 2032

Figure 19. DNA Picture

Figure 20. RNA Picture

Figure 21. Global Genome Sequencing Service Sales Value by Genome (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Genome Sequencing Service Sales Value Market Share by Genome, 2025 & 2032

Figure 23. Product Picture of Humanity

Figure 24. Product Picture of Plant

Figure 25. Product Picture of Animal

Figure 26. Product Picture of Microorganism

Figure 27. Product Picture of Virus

Figure 28. Global Genome Sequencing Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 29. Global Genome Sequencing Service Sales Value Market Share by Application, 2025 & 2032

Figure 30. North America Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 31. North America Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

Figure 32. Europe Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 33. Europe Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

Figure 34. Asia Pacific Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 35. Asia Pacific Genome Sequencing Service Sales Value by Subregion (%), 2025 vs 2032

Figure 36. South America Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 37. South America Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

Figure 38. Middle East & Africa Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 39. Middle East & Africa Genome Sequencing Service Sales Value by Country (%), 2025 vs 2032

Figure 40. Key Countries/Regions Genome Sequencing Service Sales Value (%), 2021–2032

Figure 41. United States Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 42. United States Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

Figure 43. United States Genome Sequencing Service Sales Value by Application (%), 2025 vs 2032

Figure 44. Europe Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 45. Europe Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

Figure 46. Europe Genome Sequencing Service Sales Value by Application (%), 2025 vs 2032

Figure 47. China Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 48. China Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

Figure 49. China Genome Sequencing Service Sales Value by Application (%), 2025 vs 2032

Figure 50. Japan Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 51. Japan Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

Figure 52. Japan Genome Sequencing Service Sales Value by Application (%), 2025 vs 2032

Figure 53. South Korea Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 54. South Korea Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

Figure 55. South Korea Genome Sequencing Service Sales Value by Application (%), 2025 vs 2032

Figure 56. Southeast Asia Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 57. Southeast Asia Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

Figure 58. Southeast Asia Genome Sequencing Service Sales Value by Application (%), 2025 vs 2032

Figure 59. India Genome Sequencing Service Sales Value (US$ Million), 2021–2032

Figure 60. India Genome Sequencing Service Sales Value by Type (%), 2025 vs 2032

Figure 61. India Genome Sequencing Service Sales Value by Application (%), 2025 vs 2032

Figure 62. Genome Sequencing Service Value Chain

Figure 63. Genome Sequencing Service Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Genome Sequencing Service market? zhanKai

The top companies in the global Genome Sequencing Service market are Illumina、Thermo Fisher Scientific、BGI Genomics.

What was the global market size of Genome Sequencing Service in 2032? shouQi

What is the annual compound growth rate of the global Genome Sequencing Service market size from 2026 to 2032? shouQi

What was the global market size of Genome Sequencing Service in 2026? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Genome Sequencing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Genome Sequencing Service market size was US$ 28130 million in 2025 and is forecast to reach a readjusted size of US$ 88040 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 105
USD 4250.00
(Single User License)
Global Genome Sequencing Service Market Research Report 2026
The global Genome Sequencing Service market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 88040 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 130
USD 2900.00
(Single User License)
Genome Sequencing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genome Sequencing Service was estimated to be worth US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 139
USD 3950.00
(Single User License)
Global Genome Sequencing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genome Sequencing Service market size was US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 103
USD 4250.00
(Single User License)
Global Genome Sequencing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Genome Sequencing Service market is projected to grow from US$ 23729 million in 2024 to US$ 75790 million by 2031, at a CAGR of 18.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-12-12
Pages: 160
USD 4900.00
(Single User License)
Global Genome Sequencing Service Market Research Report 2025
The global market for Genome Sequencing Service was valued at US$ 23729 million in the year 2024 and is projected to reach a revised size of US$ 75790 million by 2031, growing at a CAGR of 18.0% during the forecast period.
Published Date: 2025-12-12
Pages: 127
USD 2900.00
(Single User License)
Genome Sequencing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 134
USD 3950.00
(Single User License)
Genome Sequencing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 169
USD 3950.00
(Single User License)

Global Genome Sequencing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Genome Sequencing Service market size was US$ 28130 million in 2025 and is forecast to reach a readjusted size of US$ 88040 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 105
USD 4250.00 (Single User License)
Global Genome Sequencing Service Market Research Report 2026
The global Genome Sequencing Service market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 88040 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 130
USD 2900.00 (Single User License)
Genome Sequencing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genome Sequencing Service was estimated to be worth US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 139
USD 3950.00 (Single User License)
Global Genome Sequencing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genome Sequencing Service market size was US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 103
USD 4250.00 (Single User License)
Global Genome Sequencing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Genome Sequencing Service market is projected to grow from US$ 23729 million in 2024 to US$ 75790 million by 2031, at a CAGR of 18.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 160
USD 4900.00 (Single User License)
Global Genome Sequencing Service Market Research Report 2025
The global market for Genome Sequencing Service was valued at US$ 23729 million in the year 2024 and is projected to reach a revised size of US$ 75790 million by 2031, growing at a CAGR of 18.0% during the forecast period.
Published: 2025-12-12
Pages: 127
USD 2900.00 (Single User License)
Genome Sequencing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 134
USD 3950.00 (Single User License)
Genome Sequencing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 169
USD 3950.00 (Single User License)